Skip to content

ClearPoint Neuro, Inc.: 10-Q filed 2015-08-10

What ClearPoint Neuro, Inc. reported in its quarterly report filed 2015-08-10 (fiscal Q2 2015): 32 published measures, 89 facts as tagged in accession 0001534424-15-000196.

This filing

Form
10-Q (quarterly report)
Filed
2015-08-10
Fiscal period
fiscal Q2 2015
Accession
0001534424-15-000196 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ClearPoint Neuro, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2015-06-307,858,149USD
At 2014-12-3113,385,682USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2015-06-3013,739,245USD
At 2014-12-3113,486,012USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2015-06-30-5,881,096USD
At 2014-12-31-100,330USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2015-06-303,519,735USD
At 2014-12-319,244,006USD
At 2014-06-304,076,079USD
At 2013-12-313,516,244USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-3,060,151USD91
2015-01-01 to 2015-06-30-7,005,405USD181
2014-04-01 to 2014-06-30-1,593,100USD91
2014-01-01 to 2014-06-301,037,302USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2015-01-01 to 2015-06-307,377USD181
2014-01-01 to 2014-06-305,378USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2015-04-01 to 2015-06-30825,741USD91
2015-01-01 to 2015-06-301,836,144USD181
2014-04-01 to 2014-06-301,188,904USD91
2014-01-01 to 2014-06-302,011,435USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2015-06-30-84,282,739USD
At 2014-12-31-77,277,334USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2015-04-01 to 2015-06-3074,842,841shares91
2015-01-01 to 2015-06-3059,240,848shares181
2014-04-01 to 2014-06-3058,919,945shares91
2014-01-01 to 2014-06-3058,817,350shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2015-04-01 to 2015-06-3074,842,841shares91
2015-01-01 to 2015-06-3059,240,848shares181
2014-04-01 to 2014-06-3058,919,945shares91
2014-01-01 to 2014-06-3060,602,643shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-0.04USD/shares91
2015-01-01 to 2015-06-30-0.12USD/shares181
2014-04-01 to 2014-06-30-0.03USD/shares91
2014-01-01 to 2014-06-300.02USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-0.04USD/shares91
2015-01-01 to 2015-06-30-0.12USD/shares181
2014-04-01 to 2014-06-30-0.03USD/shares91
2014-01-01 to 2014-06-300.02USD/shares181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2015-06-30432,857USD
At 2014-12-31482,970USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2015-04-01 to 2015-06-30774,417USD91
2015-01-01 to 2015-06-301,152,309USD181
2014-04-01 to 2014-06-30184,162USD91
2014-01-01 to 2014-06-30363,908USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-2,682,588USD91
2015-01-01 to 2015-06-30-5,627,366USD181
2014-04-01 to 2014-06-30-2,215,588USD91
2014-01-01 to 2014-06-30-23,561USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2015-06-306,286,712USD
At 2014-12-3111,707,214USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2015-04-01 to 2015-06-30311,525USD91
2015-01-01 to 2015-06-30619,337USD181
2014-04-01 to 2014-06-30283,695USD91
2014-01-01 to 2014-06-30435,103USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2015-06-309,476,799USD
At 2014-12-314,919,318USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2015-06-30585,202USD
At 2014-12-31997,090USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2015-06-30487,104USD
At 2014-12-31468,949USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2015-06-302,122,523USD
At 2014-12-311,965,039USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2015-04-01 to 2015-06-302,187,393USD91
2015-01-01 to 2015-06-304,476,053USD181
2014-04-01 to 2014-06-301,929,134USD91
2014-01-01 to 2014-06-303,729,933USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2015-04-01 to 2015-06-30426,931USD91
2015-01-01 to 2015-06-30954,443USD181
2014-04-01 to 2014-06-30898,423USD91
2014-01-01 to 2014-06-301,716,044USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2015-06-3074,912,267shares
At 2014-12-3174,842,428shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2015-06-3077,652,521USD
At 2014-12-3176,428,580USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2015-06-307,890,042USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2015-06-30261,180USD
At 2014-12-31285,498USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2015-06-30157,350USD
At 2014-12-3129,220USD

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2015-01-01 to 2015-06-30137,356USD181
2014-01-01 to 2014-06-30206,076USD181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2015-04-01 to 2015-06-30115,522USD91
2015-01-01 to 2015-06-30198,209USD181
2014-04-01 to 2014-06-3025,993USD91
2014-01-01 to 2014-06-30129,379USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2015-01-01 to 2015-06-3018,154USD181
2014-01-01 to 2014-06-30-171,300USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2015-01-01 to 2015-06-30188,079USD181
2014-01-01 to 2014-06-30299,644USD181

Inspect the source

Entity
ClearPoint Neuro, Inc. / CIK 0001285550
Captured
SEC response SHA-256
42cce1b4fae43ade1c2eab56e81afab6eae0d04e4ec290dc982d64b677ec31fb

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001285550.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))